[go: up one dir, main page]

TW200738626A - Methods for treating hepatitis C - Google Patents

Methods for treating hepatitis C

Info

Publication number
TW200738626A
TW200738626A TW096101523A TW96101523A TW200738626A TW 200738626 A TW200738626 A TW 200738626A TW 096101523 A TW096101523 A TW 096101523A TW 96101523 A TW96101523 A TW 96101523A TW 200738626 A TW200738626 A TW 200738626A
Authority
TW
Taiwan
Prior art keywords
methods
treating hepatitis
compounds
compositions
virus
Prior art date
Application number
TW096101523A
Other languages
Chinese (zh)
Inventor
Gary Mitchell Karp
Guang-Ming Chen
Peter Seongwoo Hwang
Hongyu Ren
James Takasugi
Anthony Turpoff
Richard G Wilde
Alexander Arefolov
Jeffrey Campbell
Chunshi Li
Steven Paget
Nanjing Zhang
Xiaoyan Zhang
Jin Zhu
Original Assignee
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Inc filed Critical Ptc Therapeutics Inc
Publication of TW200738626A publication Critical patent/TW200738626A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides compounds, pharmaceutical compositions, and methods of using such compounds or compositions for treating infection by a virus, or for affecting viral IRES activity.
TW096101523A 2006-01-13 2007-01-15 Methods for treating hepatitis C TW200738626A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75852706P 2006-01-13 2006-01-13

Publications (1)

Publication Number Publication Date
TW200738626A true TW200738626A (en) 2007-10-16

Family

ID=39186226

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096101523A TW200738626A (en) 2006-01-13 2007-01-15 Methods for treating hepatitis C

Country Status (2)

Country Link
AR (1) AR059137A1 (en)
TW (1) TW200738626A (en)

Also Published As

Publication number Publication date
AR059137A1 (en) 2008-03-12

Similar Documents

Publication Publication Date Title
WO2007084435A3 (en) Methods for treating hepatitis c
WO2007084413A3 (en) Methods for treating hepatitis c
MX2010001650A (en) Certain nitrogen containing bicyclic chemical entities for treating viral infections.
TW200720285A (en) Nucleoside compounds for treating viral infections
TW200602064A (en) Nucleoside derivatives for treating hepatitis C virus infection
ZA200900935B (en) Hepatitis C virus inhibitors
EA201390190A1 (en) HEPATITIS C VIRUS INHIBITORS
TW200745035A (en) Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
IL195025A (en) Cyclopropyl fused indolobenzazepine derivatives and pharmaceutical compositions comprising the same as anti-hcv medicament
EA201270622A1 (en) HEPATITIS C VIRUS INHIBITORS
WO2008127364A3 (en) Antiviral compounds and use thereof
EA201001275A1 (en) CONFORMATION-LIMITED BIPHENYL DERIVATIVES FOR USE AS HEPATITIS C VIRUS INHIBITORS
MX2009004888A (en) Hepatitis c virus inhibitors.
TW200745120A (en) Indolobenzazepine HCV NS5B inhibitors
WO2008021936A3 (en) Hepatitis c virus inhibitors
EA201001273A1 (en) HEPATITIS C VIRUS INHIBITORS
MX2011008045A (en) Hepatitis c virus inhibitors.
MY152971A (en) Hepatitis c virus inhibitors
EP2234977A4 (en) Viral polymerase inhibitors
EA201370017A1 (en) HEPATITIS C VIRUS INHIBITORS
ATE522532T1 (en) COMPOUNDS FOR TREATING HEPATITIS C
PH12013500770A1 (en) Inhibitors of hepatitis c virus
EA200900156A1 (en) Pyridazine compound (VARIANTS), METHOD FOR ITS PREPARATION (VARIANTS), METHOD FOR TREATMENT OR PREVENTION OF VIRAL INFECTION WITH HEPATITIS C USING IT, compositions and medicaments based on its
MX2010001416A (en) Compounds for the treatment of hepatitis c.
MX2010005226A (en) Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors.